69.55
+0.83
+(1.21%)
At close: April 15 at 4:00:02 PM EDT
69.50
-0.05
(-0.07%)
Pre-Market: 5:28:44 AM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 4 | 4 |
| Avg. Estimate | -0.1 | 0.25 | 1 | 2.77 |
| Low Estimate | -0.48 | -0.21 | -0.4 | 1.39 |
| High Estimate | 0.21 | 0.52 | 1.86 | 5.09 |
| Year Ago EPS | 0.82 | -0.14 | -1.04 | 1 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 8 | 8 | 8 | 8 |
| Avg. Estimate | 180.23M | 188.64M | 769.1M | 828.62M |
| Low Estimate | 171.29M | 185.5M | 762.2M | 794.5M |
| High Estimate | 189.65M | 192M | 773.19M | 867.5M |
| Year Ago Sales | 137.43M | 138.04M | 614.38M | 769.1M |
| Sales Growth (year/est) | 31.14% | 36.66% | 25.18% | 7.74% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | 0.15 | 0.08 | -0 | 0.29 |
| EPS Actual | 0.82 | -0.14 | -1.27 | -0.55 |
| Difference | 0.67 | -0.22 | -1.27 | -0.84 |
| Surprise % | 459.08% | -282.60% | -38,038.14% | -287.50% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.1 | 0.25 | 1 | 2.77 |
| 7 Days Ago | -0.1 | 0.25 | 1 | 2.77 |
| 30 Days Ago | -0.1 | 0.25 | 1 | 2.77 |
| 60 Days Ago | 0.14 | 0.41 | 1.93 | 3.58 |
| 90 Days Ago | 0.14 | 0.4 | 1.93 | 3.58 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | 1 | 2 |
| Up Last 30 Days | 1 | 1 | 1 | 2 |
| Down Last 7 Days | 2 | 2 | 3 | 1 |
| Down Last 30 Days | 2 | 2 | 3 | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ANIP | 13.12% | 50.93% | 21.57% | 10.29% |
| S&P 500 | 6.76% | 5.73% | 9.19% | 14.14% |
Upgrades & Downgrades
| Reiterates | Guggenheim: Buy to Buy | 4/11/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/17/2025 |
| Initiated | Jefferies: Buy | 3/14/2025 |
| Initiated | JP Morgan: Overweight | 3/12/2025 |
| Maintains | Guggenheim: Buy to Buy | 3/5/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/3/2025 |
Related Tickers
EGRX Eagle Pharmaceuticals, Inc.
1.8000
+44.00%
PCRX Pacira BioSciences, Inc.
24.88
-0.36%
AMPH Amphastar Pharmaceuticals, Inc.
23.50
-3.77%
COLL Collegium Pharmaceutical, Inc.
27.12
+1.46%
AMRX Amneal Pharmaceuticals, Inc.
7.17
-0.55%
UTHR United Therapeutics Corporation
284.82
+0.18%
ALKS Alkermes plc
27.94
+1.45%
ELAN Elanco Animal Health Incorporated
8.24
-5.07%
AKBA Akebia Therapeutics, Inc.
1.8900
+3.28%
HCM HUTCHMED (China) Limited
14.38
-3.43%